Hallie Kuhn
Chief Tech/Sci/R&D Officer bij ALEXANDRIA REAL ESTATE EQUITIES, INC.
Profiel
Hallie Kuhn currently works at Molecular Assemblies, Inc., as Director, Eclipse Bioinnovations, Inc., as Director from 2022, Alexandria Real Estate Equities, Inc., as Vice President-Science & Technology, and Alexandria Venture Investments LLC, as Vice President of Science & Technology.
Actieve functies van Hallie Kuhn
Bedrijven | Functie | Begin |
---|---|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC. | Chief Tech/Sci/R&D Officer | - |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Director/Board Member | 15-03-2022 |
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California. | Private Equity Investor | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALEXANDRIA REAL ESTATE EQUITIES, INC. | Finance |
Bedrijven in privébezit | 3 |
---|---|
Alexandria Venture Investments LLC
Alexandria Venture Investments LLC Investment ManagersFinance Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California. | Finance |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Molecular Assemblies, Inc. develops an enzymatic deoxyribonucleic acid (DNA) synthesis technology designed to power the next generation of DNA-based products. The firm's technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. The company was founded by William Efcavitch and Curt Becker in 2013 and is headquartered in San Diego, CA. | Health Technology |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Technology Services |